PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

Brian D. Lehmann, Joshua A. Bauer, Johanna M. Schafer, Christopher S. Pendleton, Luojia Tang, Kimberly C. Johnson, Xi Chen, Justin M. Balko, Henry Gómez, Carlos L. Arteaga, Gordon B. Mills, Melinda E. Sanders, Jennifer A. Pietenpol

Research output: Contribution to journalArticlepeer-review

167 Scopus citations

Fingerprint

Dive into the research topics of 'PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences